2021 Q1 Form 10-Q Financial Statement
#000134131821000027 Filed on May 12, 2021
Income Statement
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
Revenue | $6.057M | $6.291M |
YoY Change | -3.72% | 11.11% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | ||
YoY Change | ||
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $220.0K | $210.0K |
YoY Change | 4.76% | 5.0% |
% of Gross Profit | ||
Operating Expenses | ||
YoY Change | ||
Operating Profit | ||
YoY Change | ||
Interest Expense | $787.0K | $1.395M |
YoY Change | -43.58% | 24.11% |
% of Operating Profit | ||
Other Income/Expense, Net | ||
YoY Change | ||
Pretax Income | $1.987M | $853.0K |
YoY Change | 132.94% | -18.68% |
Income Tax | $299.0K | $122.0K |
% Of Pretax Income | 15.05% | 14.3% |
Net Earnings | $1.688M | $731.0K |
YoY Change | 130.92% | -18.6% |
Net Earnings / Revenue | 27.87% | 11.62% |
Basic Earnings Per Share | $0.29 | $0.12 |
Diluted Earnings Per Share | $0.29 | $0.12 |
COMMON SHARES | ||
Basic Shares Outstanding | 5.913M | 5.987M |
Diluted Shares Outstanding | 5.914M | 5.987M |
Balance Sheet
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $127.3M | |
YoY Change | ||
Cash & Equivalents | $51.96M | $45.54M |
Short-Term Investments | $75.38M | |
Other Short-Term Assets | ||
YoY Change | ||
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | ||
YoY Change | ||
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $10.08M | $9.458M |
YoY Change | 6.57% | 1.64% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | ||
YoY Change | ||
TOTAL ASSETS | ||
Total Short-Term Assets | ||
Total Long-Term Assets | ||
Total Assets | $705.7M | $628.3M |
YoY Change | 12.32% | 13.31% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | ||
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | ||
YoY Change | ||
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $6.600M | $6.300M |
YoY Change | 4.76% | 23.53% |
Total Long-Term Liabilities | $6.600M | $6.300M |
YoY Change | 4.76% | 23.53% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | ||
Total Long-Term Liabilities | $6.600M | $6.300M |
Total Liabilities | $619.8M | $544.5M |
YoY Change | 13.83% | 15.01% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | $66.91M | $62.42M |
YoY Change | 7.19% | 4.44% |
Common Stock | $31.30M | $31.17M |
YoY Change | 0.4% | 0.48% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | $12.05M | $10.37M |
YoY Change | 16.29% | 16.89% |
Treasury Stock Shares | $1.037M | $918.2K |
Shareholders Equity | $85.96M | $83.83M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $705.7M | $628.3M |
YoY Change | 12.32% | 13.31% |
Cashflow Statement
Concept | 2021 Q1 | 2020 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $1.688M | $731.0K |
YoY Change | 130.92% | -18.6% |
Depreciation, Depletion And Amortization | $220.0K | $210.0K |
YoY Change | 4.76% | 5.0% |
Cash From Operating Activities | $1.513M | $1.386M |
YoY Change | 9.16% | 357.43% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $223.0K | $253.0K |
YoY Change | -11.86% | 194.19% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$11.34M | -$2.070M |
YoY Change | 447.83% | -69.06% |
Cash From Investing Activities | -$11.56M | -$2.319M |
YoY Change | 398.4% | -65.8% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | $652.0K | $377.0K |
YoY Change | 72.94% | 239.64% |
Debt Paid & Issued, Net | $1.500M | $1.200M |
YoY Change | 25.0% | 60.0% |
Cash From Financing Activities | 19.03M | 16.18M |
YoY Change | 17.59% | 136.87% |
NET CHANGE | ||
Cash From Operating Activities | 1.513M | 1.386M |
Cash From Investing Activities | -11.56M | -2.319M |
Cash From Financing Activities | 19.03M | 16.18M |
Net Change In Cash | 8.985M | 15.25M |
YoY Change | -41.08% | 4195.77% |
FREE CASH FLOW | ||
Cash From Operating Activities | $1.513M | $1.386M |
Capital Expenditures | $223.0K | $253.0K |
Free Cash Flow | $1.290M | $1.133M |
YoY Change | 13.86% | 422.12% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2020Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
30000 | |
CY2021Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
415000 | |
CY2021Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2021Q1 | dei |
City Area Code
CityAreaCode
|
716 | |
CY2021Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2021Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2021Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | |
CY2021Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-03-31 | |
CY2021Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2021Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2021Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2021Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
31 East Fourth Street | |
CY2021Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Dunkirk | |
CY2021Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
14048 | |
CY2021Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2021Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001341318 | |
CY2021Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
5791413 | |
CY2021Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2021Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2021Q1 | dei |
Entity File Number
EntityFileNumber
|
000-51821 | |
CY2021Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2021Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
X1 | |
CY2021Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2021Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
LAKE SHORE BANCORP, INC. | |
CY2021Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2021Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2021Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
20-4729288 | |
CY2021Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
366-4070 | |
CY2020Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
76536000 | |
CY2021Q1 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
73655000 | |
CY2020Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
1000 | |
CY2021Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
1000 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
686200000 | |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
11000 | |
CY2021Q1 | us-gaap |
Assets
Assets
|
705745000 | |
CY2021Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
2142000 | |
CY2021Q1 | dei |
Security12b Title
Security12bTitle
|
Common stock, par value $0.01 per share | |
CY2021Q1 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2021Q1 | dei |
Trading Symbol
TradingSymbol
|
LSBK | |
CY2020Q1 | lsbk |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Earned Shares
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValueEarnedShares
|
29000 | |
CY2021Q1 | lsbk |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Earned Shares
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValueEarnedShares
|
31000 | |
CY2020Q1 | lsbk |
Compensation Plan Shares Earned
CompensationPlanSharesEarned
|
1889 | |
CY2021Q1 | lsbk |
Compensation Plan Shares Earned
CompensationPlanSharesEarned
|
2057 | |
CY2020Q1 | lsbk |
Esop Shares Earned
ESOPSharesEarned
|
1984 | |
CY2021Q1 | lsbk |
Esop Shares Earned
ESOPSharesEarned
|
1984 | |
CY2020Q1 | lsbk |
Fees And Commissions Debit Card
FeesAndCommissionsDebitCard
|
169000 | |
CY2021Q1 | lsbk |
Fees And Commissions Debit Card
FeesAndCommissionsDebitCard
|
202000 | |
CY2020Q1 | lsbk |
Other Comprehensive Income Loss Reclassification Adjustment For Recovery On Previously Impaired Investments Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForRecoveryOnPreviouslyImpairedInvestmentsIncludedInNetIncomeNetOfTax
|
13000 | |
CY2021Q1 | lsbk |
Other Comprehensive Income Loss Reclassification Adjustment For Recovery On Previously Impaired Investments Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForRecoveryOnPreviouslyImpairedInvestmentsIncludedInNetIncomeNetOfTax
|
17000 | |
CY2020Q1 | lsbk |
Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Before Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeBeforeTax
|
16000 | |
CY2021Q1 | lsbk |
Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Before Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeBeforeTax
|
21000 | |
CY2020Q1 | lsbk |
Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeTax
|
-3000 | |
CY2021Q1 | lsbk |
Other Comprehensive Income Recovery On Previously Impaired Investment Securities Included In Net Income Tax
OtherComprehensiveIncomeRecoveryOnPreviouslyImpairedInvestmentSecuritiesIncludedInNetIncomeTax
|
-4000 | |
CY2020Q1 | lsbk |
Recovery On Previously Impaired Investment Securities
RecoveryOnPreviouslyImpairedInvestmentSecurities
|
16000 | |
CY2021Q1 | lsbk |
Recovery On Previously Impaired Investment Securities
RecoveryOnPreviouslyImpairedInvestmentSecurities
|
21000 | |
CY2021Q1 | lsbk |
Treasury Stock Reissued Average Cost Per Share
TreasuryStockReissuedAverageCostPerShare
|
9.39 | |
CY2020Q4 | lsbk |
Unearned Esop Shares Cost
UnearnedEsopSharesCost
|
1279000 | |
CY2021Q1 | lsbk |
Unearned Esop Shares Cost
UnearnedEsopSharesCost
|
1258000 | |
CY2020Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
|
70000 | |
CY2021Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Fair Value Disclosure
AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
|
67000 | |
CY2020Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-7000 | |
CY2021Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-42000 | |
CY2020Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
2148000 | |
CY2021Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
1345000 | |
CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
31201000 | |
CY2021Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
31230000 | |
CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
11000 | |
CY2020Q4 | us-gaap |
Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
|
3183000 | |
CY2021Q1 | us-gaap |
Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
|
2332000 | |
CY2020Q1 | us-gaap |
Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
|
500000 | |
CY2021Q1 | us-gaap |
Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
|
150000 | |
CY2020Q1 | us-gaap |
Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
|
-138000 | |
CY2021Q1 | us-gaap |
Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
|
-72000 | |
CY2020Q1 | us-gaap |
Amortization Of Esop Award
AmortizationOfESOPAward
|
28000 | |
CY2021Q1 | us-gaap |
Amortization Of Esop Award
AmortizationOfESOPAward
|
29000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
51960000 | |
CY2020Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
2779000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
15250000 | |
CY2020Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
30000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
42975000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6836514 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5823786 | |
CY2021Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5799518 | |
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
68000 | |
CY2021Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
415000 | |
CY2020Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
7781000 | |
CY2021Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
|
17394000 | |
CY2020Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
29000 | |
CY2021Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
414000 | |
CY2020Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
7705000 | |
CY2021Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
17357000 | |
CY2020Q4 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
76000 | |
CY2021Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
37000 | |
CY2021Q1 | us-gaap |
Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
|
1 | |
CY2021Q1 | us-gaap |
Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
|
33 | |
CY2020Q4 | us-gaap |
Bank Owned Life Insurance
BankOwnedLifeInsurance
|
22461000 | |
CY2021Q1 | us-gaap |
Bank Owned Life Insurance
BankOwnedLifeInsurance
|
22566000 | |
CY2020Q1 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
122000 | |
CY2021Q1 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
105000 | |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
42975000 | |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
51960000 | |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
42975000 | |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
51960000 | |
CY2020Q4 | us-gaap |
Cash And Due From Banks
CashAndDueFromBanks
|
7867000 | |
CY2021Q1 | us-gaap |
Cash And Due From Banks
CashAndDueFromBanks
|
8673000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
30289000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
45539000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
8985000 | |
CY2020Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.12 | |
CY2021Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.13 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | |
CY2021Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | |
CY2021Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
68000 | |
CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
1559000 | |
CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
885000 | |
CY2020Q4 | us-gaap |
Deferred Compensation Equity
DeferredCompensationEquity
|
118000 | |
CY2021Q1 | us-gaap |
Deferred Compensation Equity
DeferredCompensationEquity
|
280000 | |
CY2020Q4 | us-gaap |
Deposits
Deposits
|
560259000 | |
CY2021Q1 | us-gaap |
Deposits
Deposits
|
582560000 | |
CY2020Q4 | us-gaap |
Deposits Fair Value Disclosure
DepositsFairValueDisclosure
|
565655000 | |
CY2021Q1 | us-gaap |
Deposits Fair Value Disclosure
DepositsFairValueDisclosure
|
586385000 | |
CY2020Q1 | us-gaap |
Depreciation Nonproduction
DepreciationNonproduction
|
210000 | |
CY2021Q1 | us-gaap |
Depreciation Nonproduction
DepreciationNonproduction
|
215000 | |
CY2020Q4 | us-gaap |
Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
|
259000 | |
CY2021Q1 | us-gaap |
Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
|
173000 | |
CY2020Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
259000 | |
CY2021Q1 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
173000 | |
CY2020Q1 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
259000 | |
CY2021Q1 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
268000 | |
CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.12 | |
CY2020Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.12 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.29 | |
CY2020Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.12 | |
CY2020Q1 | us-gaap |
Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
|
28000 | |
CY2021Q1 | us-gaap |
Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
|
29000 | |
CY2020Q1 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
2000 | |
CY2021Q1 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
44000 | |
CY2020Q4 | us-gaap |
Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
|
29750000 | |
CY2021Q1 | us-gaap |
Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
|
28250000 | |
CY2020Q4 | us-gaap |
Federal Home Loan Bank Stock
FederalHomeLoanBankStock
|
1905000 | |
CY2021Q1 | us-gaap |
Federal Home Loan Bank Stock
FederalHomeLoanBankStock
|
1837000 | |
CY2020Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
|
5857000 | |
CY2021Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
|
6004000 | |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
6000 | |
CY2021Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
3000 | |
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
13000 | |
CY2021Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
6000 | |
CY2020Q4 | us-gaap |
Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
|
526379000 | |
CY2021Q1 | us-gaap |
Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
|
540599000 | |
CY2020Q4 | us-gaap |
Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
|
253000 | |
CY2021Q1 | us-gaap |
Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
|
249000 | |
CY2020Q4 | us-gaap |
Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
|
522897000 | |
CY2021Q1 | us-gaap |
Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
|
538059000 | |
CY2020Q4 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
3101000 | |
CY2021Q1 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
2863000 | |
CY2020Q4 | us-gaap |
Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
|
3735000 | |
CY2021Q1 | us-gaap |
Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
|
2789000 | |
CY2020Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
37000 | |
CY2021Q1 | us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
157000 | |
CY2020 | us-gaap |
Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
|
322000 | |
CY2021Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
|
251000 | |
CY2020 | us-gaap |
Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
|
16000 | |
CY2021Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
|
3000 | |
CY2020Q4 | us-gaap |
Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
|
253000 | |
CY2021Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
|
249000 | |
CY2020Q4 | us-gaap |
Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
|
253000 | |
CY2021Q1 | us-gaap |
Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
|
249000 | |
CY2021Q1 | us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
7000 | |
CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
853000 | |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
1987000 | |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
122000 | |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
299000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
67000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
38000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
|
-904000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
|
-851000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
17723000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
22301000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
|
-353000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
|
-614000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-97000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-126000 | |
CY2021Q1 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
776 | |
CY2020Q1 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
332000 | |
CY2021Q1 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
359000 | |
CY2020Q1 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
6291000 | |
CY2021Q1 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
6057000 | |
CY2020Q1 | us-gaap |
Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
|
5674000 | |
CY2021Q1 | us-gaap |
Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
|
5577000 | |
CY2020Q4 | us-gaap |
Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
|
468313000 | |
CY2021Q1 | us-gaap |
Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
|
477796000 | |
CY2020Q4 | us-gaap |
Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
|
35108000 | |
CY2021Q1 | us-gaap |
Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
|
43287000 | |
CY2020Q1 | us-gaap |
Interest Expense
InterestExpense
|
1395000 | |
CY2021Q1 | us-gaap |
Interest Expense
InterestExpense
|
787000 | |
CY2020Q1 | us-gaap |
Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
|
1201000 | |
CY2021Q1 | us-gaap |
Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
|
627000 | |
CY2020Q1 | us-gaap |
Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
|
176000 | |
CY2021Q1 | us-gaap |
Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
|
143000 | |
CY2020Q1 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
18000 | |
CY2021Q1 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
17000 | |
CY2020Q1 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
4396000 | |
CY2021Q1 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
5120000 | |
CY2020Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
4896000 | |
CY2021Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
5270000 | |
CY2020Q1 | us-gaap |
Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
|
262000 | |
CY2021Q1 | us-gaap |
Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
|
181000 | |
CY2020Q1 | us-gaap |
Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
|
289000 | |
CY2021Q1 | us-gaap |
Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
|
293000 | |
CY2020Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1396000 | |
CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
790000 | |
CY2020Q4 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
70000 | |
CY2021Q1 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
67000 | |
CY2020Q4 | us-gaap |
Interest Receivable
InterestReceivable
|
2987000 | |
CY2021Q1 | us-gaap |
Interest Receivable
InterestReceivable
|
3025000 | |
CY2020Q4 | us-gaap |
Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
|
1905000 | |
CY2021Q1 | us-gaap |
Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
|
1837000 | |
CY2020Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
2216000 | |
CY2021Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
2101000 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
600276000 | |
CY2021Q1 | us-gaap |
Liabilities
Liabilities
|
619785000 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
686200000 | |
CY2021Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
705745000 | |
CY2019Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
4267000 | |
CY2020Q1 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
4760000 | |
CY2020Q4 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
5857000 | |
CY2021Q1 | us-gaap |
Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
|
6004000 | |
CY2020Q4 | us-gaap |
Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
|
3368000 | |
CY2021Q1 | us-gaap |
Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
|
3340000 | |
CY2020Q4 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
|
526632000 | |
CY2021Q1 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
|
540848000 | |
CY2020Q4 | us-gaap |
Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
|
524143000 | |
CY2021Q1 | us-gaap |
Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
|
538184000 | |
CY2020Q4 | us-gaap |
Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
|
519551000 | |
CY2021Q1 | us-gaap |
Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
|
528977000 | |
CY2020Q4 | us-gaap |
Long Term Debt Fair Value
LongTermDebtFairValue
|
30811000 | |
CY2021Q1 | us-gaap |
Long Term Debt Fair Value
LongTermDebtFairValue
|
29105000 | |
CY2020Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
79285000 | |
CY2021Q1 | us-gaap |
Marketable Securities
MarketableSecurities
|
75382000 | |
CY2020Q1 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
173000 | |
CY2021Q1 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
133000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
16183000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
19030000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2319000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-11558000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1386000 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
731000 | |
CY2021Q1 | us-gaap |
Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
|
||
CY2020Q1 | us-gaap |
Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
|
1666000 | |
CY2021Q1 | us-gaap |
Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
|
3334000 | |
CY2020Q1 | us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
3176000 | |
CY2021Q1 | us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
14263000 | |
CY2020Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
377000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1513000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1688000 | |
CY2020Q4 | us-gaap |
Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
|
91946000 | |
CY2021Q1 | us-gaap |
Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
|
104764000 | |
CY2020Q1 | us-gaap |
Noninterest Expense
NoninterestExpense
|
3998000 | |
CY2021Q1 | us-gaap |
Noninterest Expense
NoninterestExpense
|
3953000 | |
CY2020Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
455000 | |
CY2021Q1 | us-gaap |
Noninterest Income
NoninterestIncome
|
820000 | |
CY2020Q1 | us-gaap |
Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
|
23000 | |
CY2021Q1 | us-gaap |
Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
|
25000 | |
CY2020Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
641000 | |
CY2021Q1 | us-gaap |
Occupancy Net
OccupancyNet
|
681000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
82840000 | |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
83831000 | |
CY2020Q4 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
|
221000 | |
CY2021Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
|
200000 | |
CY2020Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Cash Flows
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsCashFlows
|
16000 | |
CY2021Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Cash Flows
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsCashFlows
|
21000 | |
CY2020Q4 | us-gaap |
Other Assets
OtherAssets
|
3470000 | |
CY2021Q1 | us-gaap |
Other Assets
OtherAssets
|
2712000 | |
CY2020Q4 | us-gaap |
Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
|
2987000 | |
CY2021Q1 | us-gaap |
Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
|
3025000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
|
1064000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
|
-995000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
|
841000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
|
-786000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
|
223000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
|
-209000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
1048000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
-1016000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
828000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-803000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
220000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-213000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
841000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-786000 | |
CY2020Q1 | us-gaap |
Other Interest And Dividend Income
OtherInterestAndDividendIncome
|
66000 | |
CY2021Q1 | us-gaap |
Other Interest And Dividend Income
OtherInterestAndDividendIncome
|
6000 | |
CY2020Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
7084000 | |
CY2021Q1 | us-gaap |
Other Liabilities
OtherLiabilities
|
6643000 | |
CY2020Q1 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
343000 | |
CY2021Q1 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
302000 | |
CY2019Q4 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
|
294000 | |
CY2020Q1 | us-gaap |
Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
|
278000 | |
CY2020Q1 | us-gaap |
Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
|
||
CY2021Q1 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
2471000 | |
CY2020Q1 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
259000 | |
CY2021Q1 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
268000 | |
CY2020Q1 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
1453000 | |
CY2021Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
652000 | |
CY2020Q1 | us-gaap |
Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
|
22000 | |
CY2021Q1 | us-gaap |
Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
|
2000 | |
CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
253000 | |
CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
223000 | |
CY2020Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
1200000 | |
CY2020Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
2563000 | |
CY2021Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
5331000 | |
CY2020Q1 | us-gaap |
Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
|
22000 | |
CY2021Q1 | us-gaap |
Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
|
70000 | |
CY2020Q1 | us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
1703000 | |
CY2021Q1 | us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
3491000 | |
CY2020Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
215000 | |
CY2021Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
269000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
8974000 | |
CY2021Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
10079000 | |
CY2020Q1 | us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
500000 | |
CY2021Q1 | us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
150000 | |
CY2020Q4 | us-gaap |
Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
|
58000 | |
CY2021Q1 | us-gaap |
Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
|
51000 | |
CY2020Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
1200000 | |
CY2021Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
1500000 | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
65488000 | |
CY2021Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
66908000 | |
CY2020Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
281000 | |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
230000 | |
CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
|
68000 | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
|
71000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
85924000 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
85960000 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
|
20830 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
|
20958 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
|
1392 | |
CY2020Q1 | us-gaap |
Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
|
20830 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
|
20958 | |
CY2020Q1 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
40000 | |
CY2021Q1 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
42000 | |
CY2020Q1 | us-gaap |
Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
|
70139 | |
CY2021Q1 | us-gaap |
Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
|
35873 | |
CY2020Q1 | us-gaap |
Supplies And Postage Expense
SuppliesAndPostageExpense
|
76000 | |
CY2021Q1 | us-gaap |
Supplies And Postage Expense
SuppliesAndPostageExpense
|
64000 | |
CY2020Q1 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
14.00 | |
CY2021Q1 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
14.88 | |
CY2020Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
1012728 | |
CY2021Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
1036996 | |
CY2021Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
43834 | |
CY2020Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
11584000 | |
CY2021Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
12053000 | |
CY2020Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
377000 | |
CY2021Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
652000 | |
CY2020Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-157000 | |
CY2021Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
86000 | |
CY2020Q1 | us-gaap |
Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
|
-36000 | |
CY2021Q1 | us-gaap |
Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
|
-6000 | |
CY2021Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt"> <font style="display: inline;font-size:11pt;">To prepare these consolidated financial statements in conformity with GAAP, management of the Company made a number of estimates and assumptions relating to the reporting of assets and liabilities and the reporting of revenue and expenses. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, securities valuation estimates, evaluation of impairment of securities and income taxes.</font> </p> <p><font size="1"> </font></p> </div> </div> | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5986793 | |
CY2020Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5986793 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5913111 |